NASDAQ : ASD

Defiance Autism Impact ETF — News

$27.2212 USD

$0.06 (0.23%)

Volume
436
Average Volume
868
Market Capitalization
$1.35M
P/E Ratio
Dividend Yield
%
Price Target
Year High
$28.00
Year Low
$24.59
Day High
Day Low
Payout Ratio
Current Ratio
Source Headline
No Summer Solstice for ETFs: June Records Cap Off a Blockbuster First Half

The arrival of June usually signals a seasonal slowdown for many people, but our ETF industry clearly missed the memo. Instead of heading to the beach or stopping to watch the World Cup, the ETF ecosystem had a wave of milestones, structural changing-of-the-guards, and high-profile index provider consolidation.

etftrends.com - 2026-07-06 07:08:44

A Roundup of June's Most Notable ETF Launches

June has seen many ETF launches, from pure-play AI memory chip thematics to an autism impact fund that donates returns to nonprofits. With a record breaking 214 launches, the ETF landscape continues to expand into new markets.

etftrends.com - 2026-06-30 17:02:47

How 2026's Philanthropic ETFs ASD & DUTY Invest

The ETF ecosystem is always changing and growing. Thanks to the ETF's flexibility, transparency, and tradability, it can help investors achieve plenty of bespoke goals.

etftrends.com - 2026-06-30 07:59:44

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

SAN FRANCISCO and BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced topline results from IRIS (ML-004-002), a Phase 2 study of ML-004 in autism spectrum disorder (ASD). The study randomized 161 participants (102 adolescents, 59 adults), with prespecified analyses planned by age group and baseline irritability severity.

globenewswire.com - 2026-06-22 07:00:00

Inside ASD: The Story Behind the First Autism ETF

The Defiance Autism Impact ETF (ASD) launched June 1 as the first fund built entirely around companies tied to autism care. Behind it is a personal story from inside the firm itself.

etftrends.com - 2026-06-11 13:18:21

ETF Prime: Defiance Launches First-Ever Autism ETF

The first-ever autism ETF and the continued rise of quantum computing were both in the spotlight on this week's ETF Prime. Host Nate Geraci welcomed Sylvia Jablonski, chief investment officer of Defiance ETFs, to discuss the firm's latest launch and one of the market's top-performing funds.

etftrends.com - 2026-06-10 12:02:41

Week of June 1's Top Stories Covered SpaceX IPO, First Autism ETF

Last week's top articles on ETF Database and ETF Trends were closely connected to current events such as SpaceX's expected IPO and tech stock performance. The most-read article last week was “SpaceX IPO to Boost Aerospace ETFs?

etftrends.com - 2026-06-09 16:51:38

Investing With Purpose: Defiance Launches Autism Impact ETF

With over 5,000 funds and many launching daily in the exchange-traded fund (ETF) universe, there are a select few that can capture both industrial utility and deep human significance.

etftrends.com - 2026-06-03 12:19:31

First-Ever Autism ETF Hits Market As Health Care Innovation Theme Gains Momentum

Defiance ETFs has launched the Defiance Autism Impact ETF (NASDAQ:ASD), a first-of-its-kind ETF designed to provide investors with exposure to companies developing products, therapies, services and technologies that support individuals with autism and related neurodevelopmental conditions.

benzinga.com - 2026-06-02 18:54:08

Defiance Launches the First Autism-Impact ETF (Ticker: ASD), Donating Profits to Autism Causes *

MIAMI, June 02, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Autism Impact ETF (Ticker: ASD) , the first exchange-traded fund designed to provide targeted exposure to publicly traded companies developing products, therapies, services, technologies, and innovations supporting individuals with autism and related neurodevelopmental conditions. “As parents of a profoundly autistic child, this launch is deeply personal to our family,” said Matthew Bielski, CEO of Defiance ETFs, and Gabriella Zahn-Bielski, General Counsel of Defiance ETFs.

globenewswire.com - 2026-06-02 08:45:00

Get ASD Insider Trade Alerts

ASD Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

ASD Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade